{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T04:04:37Z","timestamp":1793851477604,"version":"4.6.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Densitometry"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.jocd.2012.11.013","type":"journal-article","created":{"date-parts":[[2013,1,31]],"date-time":"2013-01-31T02:02:29Z","timestamp":1359597749000},"page":"28-32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":82,"title":["Skeletal Effects of Primary Hyperparathyroidism: Bone Mineral Density and Fracture Risk"],"prefix":"10.1016","volume":"16","author":[{"given":"E. Michael","family":"Lewiecki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul D.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.jocd.2012.11.013_bib1","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1097\/00000478-199609000-00010","article-title":"The glandulae parathyroideae of Ivar Sandstrom. Contributions from two continents","volume":"20","author":"Carney","year":"1996","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.jocd.2012.11.013_bib2","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.amjoto.2005.11.004","article-title":"Brown tumors of the jaws associated with primary or secondary hyperparathyroidism. A clinical study and review of the literature","volume":"27","author":"Triantafillidou","year":"2006","journal-title":"Am J Otolaryngol"},{"issue":"6","key":"10.1016\/j.jocd.2012.11.013_bib3","first-page":"950","article-title":"Brown tumors mimicking bone metastases","volume":"98","author":"Meydan","year":"2006","journal-title":"J Natl Med Assoc"},{"issue":"1","key":"10.1016\/j.jocd.2012.11.013_bib4","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/0002-9343(75)90327-7","article-title":"Osteosclerosis in primary hyperparathyroidism","volume":"59","author":"Genant","year":"1975","journal-title":"Am J Med"},{"issue":"6","key":"10.1016\/j.jocd.2012.11.013_bib5","first-page":"2036","article-title":"Evaluation and management of primary hyperparathyroidism","volume":"81","author":"Silverberg","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.jocd.2012.11.013_bib6","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1210\/jc.2006-2802","article-title":"Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype","volume":"92","author":"Lowe","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.jocd.2012.11.013_bib7","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.cellsig.2009.02.012","article-title":"PTH and PTHrP signaling in osteoblasts","volume":"21","author":"Datta","year":"2009","journal-title":"Cell Signal"},{"issue":"8","key":"10.1016\/j.jocd.2012.11.013_bib8","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1210\/endo.140.8.6887","article-title":"Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation","volume":"140","author":"Lee","year":"1999","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.jocd.2012.11.013_bib9","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/jcb.20388","article-title":"Normal human osteoclasts formed from peripheral blood monocytes express PTH type 1 receptors and are stimulated by PTH in the absence of osteoblasts","volume":"95","author":"Dempster","year":"2005","journal-title":"J Cell Biochem"},{"issue":"11","key":"10.1016\/j.jocd.2012.11.013_bib10","doi-asserted-by":"crossref","first-page":"4607","DOI":"10.1210\/endo.138.11.5505","article-title":"The effects of programmed administration of human parathyroid hormone fragment (1-34) on bone histomorphometry and serum chemistry in rats","volume":"138","author":"Dobnig","year":"1997","journal-title":"Endocrinology"},{"issue":"6","key":"10.1016\/j.jocd.2012.11.013_bib11","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.bone.2007.03.017","article-title":"Molecular and cellular mechanisms of the anabolic effect of intermittent PTH","volume":"40","author":"Jilka","year":"2007","journal-title":"Bone"},{"issue":"4","key":"10.1016\/j.jocd.2012.11.013_bib12","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.tem.2009.12.002","article-title":"Does osteocytic SOST suppression mediate PTH bone anabolism?","volume":"21","author":"Kramer","year":"2010","journal-title":"Trends Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.jocd.2012.11.013_bib13","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S8756-3282(97)00078-1","article-title":"Primary hyperparathyroidism: biochemical markers and bone mineral density at multiple skeletal sites in Danish patients","volume":"21","author":"Christiansen","year":"1997","journal-title":"Bone"},{"issue":"4","key":"10.1016\/j.jocd.2012.11.013_bib14","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1210\/jcem-70-4-930","article-title":"The histomorphometry of bone in primary hyperparathyroidism: preservation of cancellous bone structure","volume":"70","author":"Parisien","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.jocd.2012.11.013_bib15","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00002142-200210000-00002","article-title":"Bone microstructure in osteoporosis: transilial biopsy and histomorphometry","volume":"13","author":"Barger-Lux","year":"2002","journal-title":"Top Magn Reson Imaging"},{"issue":"5","key":"10.1016\/j.jocd.2012.11.013_bib16","first-page":"1562","article-title":"On the mechanism of cancellous bone preservation in postmenopausal women with mild primary hyperparathyroidism","volume":"84","author":"Dempster","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.jocd.2012.11.013_bib17","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.bone.2007.03.020","article-title":"Preserved three-dimensional cancellous bone structure in mild primary hyperparathyroidism","volume":"41","author":"Dempster","year":"2007","journal-title":"Bone"},{"issue":"3","key":"10.1016\/j.jocd.2012.11.013_bib18","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/jbmr.5650040302","article-title":"Skeletal disease in primary hyperparathyroidism","volume":"4","author":"Silverberg","year":"1989","journal-title":"J Bone Miner Res"},{"issue":"9","key":"10.1016\/j.jocd.2012.11.013_bib19","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1002\/jbmr.5650100917","article-title":"Bone structure in postmenopausal hyperparathyroid, osteoporotic, and normal women","volume":"10","author":"Parisien","year":"1995","journal-title":"J Bone Miner Res"},{"issue":"Suppl 2","key":"10.1016\/j.jocd.2012.11.013_bib20","first-page":"N98","article-title":"Bone densitometry in asymptomatic primary hyperparathyroidism","volume":"17","author":"Miller","year":"2002","journal-title":"J Bone Miner Res"},{"issue":"1","key":"10.1016\/j.jocd.2012.11.013_bib21","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1359\/JBMR.050910","article-title":"Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993-2001: an update on the changing epidemiology of the disease","volume":"21","author":"Wermers","year":"2006","journal-title":"J Bone Miner Res"},{"issue":"3","key":"10.1016\/j.jocd.2012.11.013_bib22","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0889-8529(05)70145-6","article-title":"Natural history of primary hyperparathyroidism","volume":"29","author":"Silverberg","year":"2000","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"1","key":"10.1016\/j.jocd.2012.11.013_bib23","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1365-2362.1988.tb01163.x","article-title":"Prevalence of hypercalcaemia in a health survey: a 14-year follow-up study of serum calcium values","volume":"18","author":"Palmer","year":"1988","journal-title":"Eur J Clin Invest"},{"issue":"2","key":"10.1016\/j.jocd.2012.11.013_bib24","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1210\/jc.2008-1763","article-title":"Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop","volume":"94","author":"Bilezikian","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2012.11.013_bib25","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1056\/NEJM199910213411701","article-title":"A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery","volume":"341","author":"Silverberg","year":"1999","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.jocd.2012.11.013_bib26","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1210\/jc.2007-1215","article-title":"The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15-years","volume":"93","author":"Rubin","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.jocd.2012.11.013_bib27","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1007\/s00268-011-1062-2","article-title":"Prevalence of primary hyperparathyroidism and impact on bone mineral density in elderly men: MrOs Sweden","volume":"35","author":"Siilin","year":"2011","journal-title":"World J Surg"},{"issue":"7041","key":"10.1016\/j.jocd.2012.11.013_bib28","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1136\/bmj.312.7041.1254","article-title":"Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures","volume":"312","author":"Marshall","year":"1996","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.jocd.2012.11.013_bib29","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1359\/jbmr.060708","article-title":"BMD and risk of hip and nonvertebral fractures in older men: a prospective study and comparison with older women","volume":"21","author":"Cummings","year":"2006","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2012.11.013_bib30","first-page":"N2","article-title":"Summary statement from a Workshop on Asymptomatic Primary Hyperparathyroidism: a perspective for the 21st century","volume":"17","author":"Bilezikian","year":"2002","journal-title":"J Bone Miner Res"},{"issue":"Suppl 5","key":"10.1016\/j.jocd.2012.11.013_bib31","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00198-003-1482-4","article-title":"Bone strength in primary hyperparathyroidism","volume":"14","author":"Bilezikian","year":"2003","journal-title":"Osteoporos Int"},{"issue":"10","key":"10.1016\/j.jocd.2012.11.013_bib32","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1359\/jbmr.2002.17.10.1741","article-title":"Parathyroid hormone and periosteal bone expansion","volume":"17","author":"Parfitt","year":"2002","journal-title":"J Bone Miner Res"},{"issue":"10","key":"10.1016\/j.jocd.2012.11.013_bib33","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1359\/jbmr.1999.14.10.1700","article-title":"Primary hyperparathyroidism and the risk of fracture: a population-based study","volume":"14","author":"Khosla","year":"1999","journal-title":"J Bone Miner Res"},{"issue":"7261","key":"10.1016\/j.jocd.2012.11.013_bib34","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1136\/bmj.321.7261.598","article-title":"Cohort study of risk of fracture before and after surgery for primary hyperparathyroidism","volume":"321","author":"Vestergaard","year":"2000","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.jocd.2012.11.013_bib35","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1210\/jc.2008-2006","article-title":"Morphometric vertebral fractures in postmenopausal women with primary hyperparathyroidism","volume":"94","author":"Vignali","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2012.11.013_bib36","doi-asserted-by":"crossref","first-page":"959","DOI":"10.7326\/0003-4819-109-12-959","article-title":"Mild asymptomatic primary hyperparathyroidism is not a risk factor for vertebral fractures","volume":"109","author":"Wilson","year":"1988","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.jocd.2012.11.013_bib37","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1046\/j.0954-6820.2003.01237.x","article-title":"Parathyroid surgery is associated with a decreased risk of hip and upper arm fractures in primary hyperparathyroidism: a controlled cohort study","volume":"255","author":"Vestergaard","year":"2004","journal-title":"J Intern Med"},{"issue":"6","key":"10.1016\/j.jocd.2012.11.013_bib38","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1365-2796.1993.tb01017.x","article-title":"The risk of hip fractures in patients with primary hyperparathyroidism: a population-based cohort study with a follow-up of 19 years","volume":"234","author":"Larsson","year":"1993","journal-title":"J Intern Med"},{"issue":"Suppl 2","key":"10.1016\/j.jocd.2012.11.013_bib39","first-page":"S97","article-title":"Asymptomatic primary hyperparathyroidism discovered by multichannel biochemical screening: clinical course and considerations bearing on the need for surgical intervention","volume":"6","author":"Parfitt","year":"1991","journal-title":"J Bone Miner Res"},{"issue":"1","key":"10.1016\/j.jocd.2012.11.013_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jocd.2011.11.004","article-title":"Proceedings of the 2011 Santa Fe Bone symposium","volume":"15","author":"Lewiecki","year":"2012","journal-title":"J Clin Densitom"},{"issue":"2","key":"10.1016\/j.jocd.2012.11.013_bib41","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1210\/jc.2008-1760","article-title":"Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop","volume":"94","author":"Silverberg","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.jocd.2012.11.013_bib42","doi-asserted-by":"crossref","first-page":"4641","DOI":"10.1210\/jc.2002-021404","article-title":"Normocalcemic primary hyperparathyroidism: evidence for a generalized target-tissue resistance to parathyroid hormone","volume":"88","author":"Maruani","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.jocd.2012.11.013_bib43","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1590\/S0004-27302010000200004","article-title":"Normocalcemic primary hyperparathyroidism","volume":"54","author":"Bilezikian","year":"2010","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"10.1016\/j.jocd.2012.11.013_bib44","series-title":"Assessment of fracture risk and its application to screening for postmenopausal osteoporosis","year":"1994"},{"issue":"3","key":"10.1016\/j.jocd.2012.11.013_bib45","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s00223-010-9454-0","article-title":"Increased fracture risk in normocalcemic postmenopausal women with high parathyroid hormone levels: a 16-year follow-up study","volume":"88","author":"Rejnmark","year":"2011","journal-title":"Calcif Tissue Int"},{"issue":"10","key":"10.1016\/j.jocd.2012.11.013_bib46","first-page":"801","article-title":"Catabolic and anabolic actions of parathyroid hormone on the skeleton","volume":"34","author":"Silva","year":"2011","journal-title":"J Endocrinol Invest"}],"container-title":["Journal of Clinical Densitometry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094695012002429?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094695012002429?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T21:37:25Z","timestamp":1761082645000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094695012002429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S1094695012002429"],"URL":"https:\/\/doi.org\/10.1016\/j.jocd.2012.11.013","relation":{},"ISSN":["1094-6950"],"issn-type":[{"value":"1094-6950","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Skeletal Effects of Primary Hyperparathyroidism: Bone Mineral Density and Fracture Risk","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Densitometry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocd.2012.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The International Society for Clinical Densitometry. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}